ChrysCapital Acquires Novartis India Majority Stake for Rs 860 Share Price
Swiss pharmaceutical giant Novartis AG has officially signed a definitive agreement to sell its controlling stake in Novartis India Limited to ChrysCapital. The deal marks a significant shift in the Indian pharmaceutical landscape and ends months of speculation regarding the future of the listed Indian entity. This strategic move allows the private equity firm to take charge of a portfolio rich in established medical brands while the Swiss parent focuses…










